Morepen Laboratories Limited – NSE:MOREPENLAB.NS

Morepen Laboratories Limited stock price today

INR 57.35
-19.50
-25.38%
Financial Health
0
1
2
3
4
5
6
7
8
9

Morepen Laboratories Limited stock price monthly change

+38.36%
month

Morepen Laboratories Limited stock price quarterly change

+38.36%
quarter

Morepen Laboratories Limited stock price yearly change

+53.87%
year

Morepen Laboratories Limited key metrics

Market Cap
 43.12B
Enterprise value
 16.12B
P/E
 30.88
EV/Sales
 1.13
EV/EBITDA
 18.48
Price/Sales
 1.10
Price/Book
 2.13
PEG ratio
 6.67
EPS
 1.51
Revenue
 16.27B
EBITDA
 1.68B
Income
 761.19M
Revenue Q/Q
 -0.98%
Revenue Y/Y
 14.81%
Profit margin
 3.01%
Oper. margin
 3.85%
Gross margin
 32.72%
EBIT margin
 3.85%
EBITDA margin
 10.34%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Morepen Laboratories Limited stock price history

Morepen Laboratories Limited stock forecast

Morepen Laboratories Limited financial statements

Profit Margin

Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Profit margin
Jun 2023 4.01B 146.33M 3.65%
Sep 2023 4.21B 212.56M 5.04%
Dec 2023 4.44B 319.9M 7.2%
Mar 2024 3.60B 82.4M 2.29%
MOREPENLAB.NS income statement history
0%
Yield TTM
Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Payout ratio
Payout ratio 0%
Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Dividend Yield
2016
2017
2019 0.06%
2020 0.11%
2022
MOREPENLAB.NS dividends history

Debt to Assets

Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Debt to assets
Jun 2023 0 0
Sep 2023 11937817000 4.05B 33.95%
Dec 2023 0 0
Mar 2024 12932051000 4.45B 34.49%
MOREPENLAB.NS balance sheet history

Cash Flow

Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Cash Flow
Jun 2023 154.28M 0 0
Sep 2023 153.73M 0 0
Dec 2023 168.90M 0 0
Mar 2024 0 0 0
MOREPENLAB.NS cash flow history

Morepen Laboratories Limited alternative data

Morepen Laboratories Limited
Employees

Morepen Laboratories Limited (NSE:MOREPENLAB.NS): Employee count
Aug 2023 1,607
Sep 2023 1,607
Oct 2023 1,649
Nov 2023 1,649
Dec 2023 1,649
Jan 2024 1,649
Feb 2024 1,649
Mar 2024 1,649
Apr 2024 1,649
May 2024 1,649
Jun 2024 1,649
Jul 2024 1,649

Morepen Laboratories Limited other data

Morepen Laboratories Limited
Executives

Insider Compensation
Mr. Sushil Suri B.Sc., F.C.A., FCA (1964) Chairman & MD
 $53,850,000
Mr. Sanjay Suri (1968) Whole-Time Director
 $37,970,000
Mr. Ajay Kumar Sharma (1967) Chief Financial Officer
 $9,800,000
Mr. Vipul Kumar Srivastava (1985) Company Sec. & Compliance Officer
 $1,840,000
Dr. Arun Kumar Sinha M.Sc., Ph.D. (1951) Whole-Time Director
 $900,000

Frequently Asked Questions (FAQ)

  • What's the price of Morepen Laboratories Limited stock today?

    One share of Morepen Laboratories Limited stock can currently be purchased for approximately $57.35.

  • When is Morepen Laboratories Limited's next earnings date?

    Morepen Laboratories Limited is estimated to report earnings on Monday, 11 Aug 2025.

  • Does Morepen Laboratories Limited pay dividends?

    No, Morepen Laboratories Limited does not pay dividends.

  • How much money does Morepen Laboratories Limited make?

    Morepen Laboratories Limited has a market capitalization of 43.12B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.4% to 17.02B US dollars.

  • What is Morepen Laboratories Limited's stock symbol?

    Morepen Laboratories Limited is traded on the NSE under the ticker symbol "MOREPENLAB.NS".

  • What is Morepen Laboratories Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Morepen Laboratories Limited?

    Shares of Morepen Laboratories Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Morepen Laboratories Limited's key executives?

    Morepen Laboratories Limited's management team includes the following people:

    • Mr. Sushil Suri B.Sc., F.C.A., FCA Chairman & MD(age: 61, pay: $53,850,000)
    • Mr. Sanjay Suri Whole-Time Director(age: 57, pay: $37,970,000)
    • Mr. Ajay Kumar Sharma Chief Financial Officer(age: 58, pay: $9,800,000)
    • Mr. Vipul Kumar Srivastava Company Sec. & Compliance Officer(age: 40, pay: $1,840,000)
    • Dr. Arun Kumar Sinha M.Sc., Ph.D. Whole-Time Director(age: 74, pay: $900,000)

  • How many employees does Morepen Laboratories Limited have?

    As Jul 2024, Morepen Laboratories Limited employs 1,649 workers.

  • When Morepen Laboratories Limited went public?

    Morepen Laboratories Limited is publicly traded company for more then 29 years since IPO on 1 Jan 1996.

  • What is Morepen Laboratories Limited's official website?

    The official website for Morepen Laboratories Limited is morepen.com.

  • How can i contact Morepen Laboratories Limited?

    Morepen Laboratories Limited can be reached via phone at +91 11 2332 4443.

Morepen Laboratories Limited company profile:

Morepen Laboratories Limited

morepen.com
Exchange:

NSE

Full time employees:

2,152

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.

+91 11 2332 4443
409, Antriksh Bhawan
New Delhi, 110001

:
ISIN: INE083A01026
CUSIP: Y6138R139